Micell Technologies, Inc. is a privately-held, early-stage biomedical company dedicated to advancing combination product therapies in the cardiovascular, orthopedic, and drug-delivery areas. The company's Supercritical Fluid Technology consists of patented processes and methods for surface modifications of medical devices with specific focus on improvements to current polymer based drug-eluting technologies. Micell has exclusively licensed technology patents from Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.